NEXGEL, Inc.

NasdaqCM NXGL

NEXGEL, Inc. Current Liabilities for the quarter ending September 30, 2024: USD 3.05 M

NEXGEL, Inc. Current Liabilities is USD 3.05 M for the quarter ending September 30, 2024, a 85.51% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

NEXGEL, Inc. Current Liabilities for the quarter ending September 30, 2023 was USD 1.64 M, a 47.35% change year over year.
NEXGEL, Inc. Current Liabilities for the quarter ending September 30, 2022 was USD 1.11 M, a -53.72% change year over year.
NEXGEL, Inc. Current Liabilities for the quarter ending September 30, 2021 was USD 2.41 M, a 156.55% change year over year.
NEXGEL, Inc. Current Liabilities for the quarter ending September 30, 2020 was USD 939.00 K.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

NasdaqCM: NXGL

NEXGEL, Inc.

CEO	Mr. Adam R. Levy
IPO Date	Dec. 22, 2021
Location	United States
Headquarters	2150 Cabot Boulevard West
Employees	19
Sector	Materials
Industries Plastics 3D Printing Biotechnology Chemicals & Advanced Materials Cleaning Supplies Composite Materials Medical Instruments Personal Care

Description

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

Key trends

Past 5 years